Cannabis Stock Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI) Makes TSX Top Gainer List on Third Quarter Results
Organigram Global Inc. (OGI) reported Q3 fiscal 2026 results for the quarter ended June 30, 2026. The company said gross revenue rose to $145.1 million (+32% YoY), net revenue to $105.8 million (+49%), and adjusted EBITDA to $13.4 million (+136%). It cited Sanity Group’s acquisition contribution and noted a TSX share-price gain in early trading.
How this was made
The 30-second read
Why it matters
The reported acceleration in revenue and adjusted EBITDA, plus improved adjusted gross margin and Canadian operational efficiencies, is the core catalyst for re-pricing OGI. However, the cash flow profile (FCF outflow) and reliance on acquisition contributions may temper follow-through.
Market read
OGI’s Q3 results provide fresh, company-specific operating metrics and acquisition contribution details that can drive near-term trading and sentiment in cannabis equities.
What to watch
The article highlights non-cash fair value gains affecting net income, so traders may discount headline net income versus cash generation and sustainability of margins.
Background
Organigram’s Q3 FY2026 includes the first quarter of financial contributions from its Sanity Group acquisition (closed April 15, 2026).
Ticker impact
Organigram reported Q3 FY2026 results, including net revenue up 49% and adjusted EBITDA up 136%, with Sanity Group contributing since April 15.
Likely supports continued upside momentum versus prior expectations, but magnitude may fade if investors focus on free cash flow weakness and working-capital drag.
The article provides multiple concrete operating metrics (revenue, adjusted EBITDA, margins) and ties them to acquisition contribution, but it lacks guidance, consensus context, or balance-sheet detail beyond FCF.
Market effects
Strong Canadian market-share claims plus European expansion progress may improve sentiment toward Canadian cannabis operators with international distribution platforms.
TSX-listed cannabis names may see sympathy flows if OGI’s results are viewed as evidence of sector stabilization.
European growth milestones tied to Sanity (Switzerland, Poland, UK) can influence how investors price cross-border cannabis platforms.
Counterpoint
Despite adjusted EBITDA growth, free cash flow was still an outflow, suggesting earnings quality may be pressured by working-capital needs.
Key entities
- companyOrganigram Global Inc.
NASDAQ: OGI, TSX: OGI. Reported Q3 FY2026 results and first quarter of Sanity Group contributions.
- companySanity Group
Acquired April 15, 2026. Contributed approximately EUR25 million (C$40 million) net revenue in the quarter and advanced European expansion plans.
- personJames Yamanaka
CEO quoted on Q3 milestone and Sanity performance in line with expectations.
- personPaolo De Luca
Named executive departing after nine years; previously CFO and Chief Strategy Officer.
